Previous 10 | Next 10 |
Inotiv (NOTV) enters agreement to purchase Envigo RMS Holding, a leading global provider of research models and services. Transaction consideration consists of $200M of cash and ~9.36M company common share. Company has received committed debt financing to fund the cash portion ...
-- Expected to establish a leading global provider of a full spectrum of pre-clinical solutions -- -- Expected to be immediately accretive to Inotiv earnings and margins before synergies -- -- Expected to enhance scale, broaden customer base and create significant cross-se...
WEST LAFAYETTE, Ind., Aug. 31, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”) , a leading contract research organization specializing in nonclinical and analytical drug discovery and de...
Inotiv, Inc. (NOTV) Q3 2021 Earnings Conference Call August 11, 2021, 04:30 PM ET Company Participants Kalle Ahl - IR, The Equity Group Robert Leasure - President and Chief Executive Officer Beth Taylor - VP, Finance and Chief Financial Officer John Sagartz - Chief Strategy Officer Conference...
WEST LAFAYETTE, Ind., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”) , a leading contract research organization specializing in nonclinical and analytical drug discovery and d...
Inotiv (NOTV -1.7%) announced the acquisition of Gateway Pharmacology Laboratories LLC, which according to one company executive, would help it to focus on drugs targeting kidney and heart diseases. “This acquisition of Gateway (GTW) extends an array of in vivo capability and inte...
WEST LAFAYETTE, Ind., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”) , a leading contract research organization specializing in nonclinical and analytical drug discovery and de...
Summers Value Partners is a boutique value manager that uses a focused, long-term approach to investing in areas of the market where most managers are unwilling or unable to participate. The biggest contributor in the second quarter was Inotiv (NOTV), which appreciated by 33% and was ...
WEST LAFAYETTE, Ind., July 22, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”) , a leading contract research organization specializing in nonclinical and analytical drug discovery and d...
Inotiv (NOTV) announced the purchase of physical assets from a Tennessee-based laboratory services provider that has ceased operations.With the acquisition, the company intends to accelerate its expansion of services to biopharma firms focused on cell and gene therapy as well as tra...
News, Short Squeeze, Breakout and More Instantly...
WEST LAFAYETTE, Ind., June 10, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and rela...